Udenafil

CAS No. 268203-93-6

Udenafil ( DA-8159 )

Catalog No. M13819 CAS No. 268203-93-6

A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 Get Quote
10MG 110 Get Quote
25MG 215 Get Quote
50MG 345 Get Quote
100MG 503 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Udenafil
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
  • Description
    A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.Sexual Dysfunction Approved
  • Synonyms
    DA-8159
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    Endocrinology
  • Indication
    Sexual Dysfunction

Chemical Information

  • CAS Number
    268203-93-6
  • Formula Weight
    516.66
  • Molecular Formula
    C25H36N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33 mg/mL
  • SMILES
    O=S(C1=CC=C(OCCC)C(C(NC2=C3N(C)N=C2CCC)=NC3=O)=C1)(NCCC4N(C)CCC4)=O
  • Chemical Name
    Benzenesulfonamide, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Salem EA, et al. Curr Opin Investig Drugs. 2006 Jul;7(7):661-9.
2. Lee CH, et al. J Sex Med. 2010 Jul;7(7):2564-71.
3. Kang HE, et al. Br J Pharmacol. 2009 Mar;156(6):1009-18.
molnova catalog
related products
  • Tetomilast

    Tetomilast (OPC-6535) is a superoxide anion production inhibitor that inhibits PDE4 and proinflammatory functions.

  • UK-369003

    UK-369003 (Gisadenafil besylate) is a novel, potent, selective, orally bioavailable PDE5 inhibitor with IC50 of 1.23 nM.

  • Anagrelide

    Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor.